Ds Healthcare Group Comments on Recent Developments
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Rodman & Renshaw Reinstates DS Healthcare (DSKX) at Buy
March 31, 2016 7:47 AM EDTRodman & Renshaw reinstated coverage on DS Healthcare (NASDAQ: DSKX) with a Buy rating and a price target of $1.50. Analyst Raghuram Selvaraju said clarity on accounting restatements indicates limited damage.
"In the wake of additional information disclosed by DS Healthcare regarding the scope and nature... More
